 SOUTH SAN FRANCISCO, Calif., May 31, 2022 GLOBE NEWSWIRE -- Nkarta, Inc. Nasdaq: NKTX, a biopharmaceutical company developing engineered natural killer NK cell therapies to treat cancer, today announced its participation at an upcoming investor conference: 